Copyright
©The Author(s) 2024.
World J Crit Care Med. Dec 9, 2024; 13(4): 97631
Published online Dec 9, 2024. doi: 10.5492/wjccm.v13.i4.97631
Published online Dec 9, 2024. doi: 10.5492/wjccm.v13.i4.97631
Variable | Data |
Sex | Male: 77 (n = 14) |
Female: 23 (n = 4) | |
Body mass index, mean ± SD | 30.6 ± 7.85 |
Age, mean ± SD | 53 ± 15.80 |
Comorbidities | |
Hypertension | 33.33 (n = 6) |
Heart disease | 0 |
Diabetes mellitus | 27.77 (n = 5) |
CKD | 22.22 (n = 4) |
Asthma | 0 |
Smoking | 5.55 (n = 1) |
Days from onset to severe pneumonia diagnosis, mean ± SD | 8.94 ± 3.90 |
APACHE II score, median (range) | 14.5 (29-6) |
Initial ARDS respiratory support | |
Low flow oxygen cannula | 5.55 (n = 1) |
Oxygen mask with bag | 44..44 (n = 8) |
Invasive mechanical ventilator | 50 (n = 9) |
- Citation: Vásquez-Torres J, Dávila-Collado R, Abdalah-Perez L, Jarquin-Duran O, Latino JS, Espinoza JL. Beyond conventional care: The therapeutic potential of hemoperfusion in severe COVID-19. World J Crit Care Med 2024; 13(4): 97631
- URL: https://www.wjgnet.com/2220-3141/full/v13/i4/97631.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v13.i4.97631